GSK (GLAXF) Inventories, Finished Goods: $0 Mil (As of Mar. 2026)


GLAXF GSK PLC GLAXF
75 GF Score
Price $25.33
GF Value $21.09
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is GSK Inventories, Finished Goods?

GSK GLAXF 75 Inventories, Finished Goods is $0 Mil as of Mar. 2026. GuruFocus rates GLAXF with a GF Score™ of 75/100 and a GF Value™ of $21.09 (Modestly Overvalued). The stock has 1 warning sign investors should review.

GSK's quarterly finished goods increased from Sep. 2025 ($0 Mil) to Dec. 2025 ($2,165 Mil) but then declined from Dec. 2025 ($2,165 Mil) to Mar. 2026 ($0 Mil).

GSK's annual finished goods increased from Dec. 2023 ($1,842 Mil) to Dec. 2024 ($2,054 Mil) and increased from Dec. 2024 ($2,054 Mil) to Dec. 2025 ($2,165 Mil).

GSK Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for GSK's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK Inventories, Finished Goods Chart

GSK Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,821.81 1,563.95 1,841.77 2,054.36 2,164.66

GSK Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 2,164.66 0.00
GLAXF
75GF Score
GSK PLC GLAXF
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GSK Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of $0 Mil mean?
GSK (GLAXF) has a Inventories, Finished Goods of $0 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on GSK and its competitors.
Is GSK's Inventories, Finished Goods too high?
GSK's current Inventories, Finished Goods is $0 Mil. Overall, GSK has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does GSK's Inventories, Finished Goods compare to LLY and JNJ?
GSK's Inventories, Finished Goods of $0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on GSK and its competitors. GSK's current Inventories, Finished Goods is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GSK stock overvalued right now?
Based on GuruFocus' analysis, GSK (GLAXF) is currently considered Modestly Overvalued. The stock's GF Value™ is $21.09, compared to a current price of $25.33 — trading 20.1% above its estimated fair value. The current Inventories, Finished Goods is $0 Mil. GSK's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For GSK (GLAXF), the current Inventories, Finished Goods is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GSK (GLAXF) Overvalued in 2026?

Based on GuruFocus' analysis, GSK stock appears to be overvalued. The current stock price of $25.33 is trading 20.1% above its estimated GF Value™ of $21.09. GuruFocus considers GSK to be Modestly Overvalued.

Key valuation signals for GLAXF:

  • Inventories, Finished Goods: $0 Mil
  • GF Value™: $21.09 vs. price of $25.33 (20.1% above fair value)
  • GF Score™: 75/100 with 1 warning sign

No single metric tells the full story. See the GLAXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GSK Business Description

Address 79 New Oxford Street, London, GBR, WC1A 1DG
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
75GF Score

Get the complete analysis for GLAXF

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.33
Price
$21.09
GF Value